| 1.09 Delayed Data As of Aug 16 |  -0.01 / -0.91%Today’s Change | 1.02 Today|||52-Week Range 2.60 | -9.17% Year-to-Date |
| Previous close | 1.10 |
| Today’s open | 1.09 |
| Day’s range | 1.09 - 1.14 |
| Volume | 24,665 |
| Average volume (3 months) | 132,395 |
| Market cap | $45.3M |
| Earnings growth (last year) | -46.47% |
| Earnings growth (this year) | +32.91% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | 0.6 |
| Price/Sales | -- |
| Price/Book | 0.36 |
| Today’s change | Today’s % change | |
|---|---|---|
| BLPHBellerophon Therapeu... | +0.01 | +0.99% |
| CLSDClearside Biomedical... | +0.02 | +1.72% |
| FBIOPFortress Biotech Inc | +0.13 | +0.59% |
| FWPForward Pharma A/S | -0.01 | -1.08% |
| Next reporting date | November 11, 2019 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | $63.1M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Glenn P. Sblendorio |
Chief Operating Officer & Senior Vice President Keith Westby |
Corporate headquarters New York, New York |
